2024-514413-36-00招募中1 期
A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 12
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Operations
Scientific
Bluesky Immunotherapies GmbH
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal CancerOropharyngeal Squamous Cell Carcinoma (SCC)NCT06589609BlueSky Immunotherapies GmbH12
招募中
1 期
Phase I study of Multiple-Vaccine Therapy in Patient with Refractory Breast Cancer to Chemotherapy.Breast CancerJPRN-UMIN000002408Department of Breast and Endocrine Surgery, Juntendo University School of Medicine6
已完成
1 期
Phase I study of Multiple-Vaccine Therapy in Patient with Refractory Non-Small-Cell Lung Cancer to Chemotherapy.on-Small-Cell Lung CancerJPRN-UMIN000002141Department of Respiratory Medicine, Juntendo University School of Medicine9
已完成
不适用
Pilot Phase III immunotherapy study in early breast cancer patients using oxidized mannan-MUC1Early breast cancer (Stage II)BreastCancerISRCTN71711835Prolipsis Medical Center (Greece)31
已完成
1 期
A pilot trial of immunotherapy with WT1 peptide vaccine for pediatric patients with bone or soft tissue sarcoma following conventional chemotherapy.Osteosarcoma Soft tissue sarcoma neuroblastoma Pediatric bone, soft tissue sarcoma at high risk of recurrence.JPRN-UMIN000005312Osaka Universty22